U.S. Physical Therapy (USPH) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.75
- EPS estimate
- $0.81
- EPS surprise
- −7.82%
- Revenue surprise
- +1.28%
- Revenue
- $214.1M
- Revenue estimate
- $211.4M
- Reported
- Aug 6, 2026
U.S. Physical Therapy reported Q2 2026 results on August 6, 2026. Earnings per share were $0.75, below the $0.81 estimate by 7.82%. Revenue was $214.1 million, 1.28% above the $211.4 million consensus. Compared with Q2 2025, revenue rose about 8.5% from $197.3 million, while EPS fell about 7.4% from $0.81.
Q2 2026 revenue was the highest in the table. Annual revenue rose from $553.2 million in 2022 to $780.9 million in 2025, about 41% more. EPS has not kept pace. Annual EPS was $2.71 in 2022, $2.56 in 2023, $2.44 in 2024 and $2.62 in 2025. The first half of 2026 totals $1.21, about 6% below the $1.29 of the same period a year earlier. The highest quarterly EPS here is still Q2 2022, at $0.90. The last four quarters all missed the EPS estimate, after beats in Q1 and Q2 2025. Over the full 20 quarters, the record is 11 beats and 9 misses.
U.S. Physical Therapy reported Q3 results between November 2 and November 8 in each of the past five years. That points to early November 2026 for the next report. It will show whether the run of EPS misses continues while revenue keeps growing.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | $0.81 | $0.75 | −7.82% | $214.1M | SEC |
| Q1 2026 | May 6, 2026 | $0.52 | $0.46 | −11.04% | $198.3M | SEC |
| Q4 2025 | Feb 26, 2026 | $0.68 | $0.67 | −0.80% | $202.7M | SEC |
| Q3 2025 | Nov 6, 2025 | $0.67 | $0.66 | −1.43% | $197.1M | SEC |
| Q2 2025 | Aug 7, 2025 | $0.72 | $0.81 | +13.26% | $197.3M | SEC |
| Q1 2025 | May 7, 2025 | $0.43 | $0.48 | +11.50% | $183.8M | SEC |
| Q4 2024 | Feb 27, 2025 | $0.69 | $0.51 | −25.94% | $180.4M | SEC |
| Q3 2024 | Nov 6, 2024 | $0.68 | $0.69 | +0.88% | $168.0M | SEC |
| Q2 2024 | Aug 14, 2024 | $0.82 | $0.73 | −10.82% | $167.2M | SEC |
| Q1 2024 | May 7, 2024 | $0.56 | $0.51 | −8.57% | $155.7M | SEC |
| Q4 2023 | Feb 28, 2024 | $0.57 | $0.59 | +4.22% | $154.8M | SEC |
| Q3 2023 | Nov 8, 2023 | $0.62 | $0.62 | +0.57% | $150.0M | SEC |
| Q2 2023 | Aug 9, 2023 | $0.75 | $0.76 | +1.60% | $151.5M | SEC |
| Q1 2023 | May 5, 2023 | $0.55 | $0.59 | +8.08% | $148.5M | SEC |
| Q4 2022 | Feb 23, 2023 | $0.57 | $0.58 | +1.75% | $141.2M | SEC |
| Q3 2022 | Nov 2, 2022 | $0.63 | $0.58 | −7.64% | $139.6M | — |
| Q2 2022 | Aug 4, 2022 | $0.95 | $0.90 | −4.86% | $140.7M | — |
| Q1 2022 | May 5, 2022 | $0.63 | $0.65 | +3.83% | $131.7M | — |
| Q4 2021 | Feb 24, 2022 | $0.69 | $0.72 | +4.65% | $129.8M | — |
| Q3 2021 | Nov 4, 2021 | $0.78 | $0.85 | +9.25% | $125.9M | — |
Quarterly revenue
Frequently asked questions
When did U.S. Physical Therapy (USPH) last report earnings?
U.S. Physical Therapy last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did USPH beat earnings estimates?
No. U.S. Physical Therapy reported EPS of $0.75 for Q2 2026 against a $0.81 estimate — a 7.82% miss.
How much revenue did USPH report last quarter?
U.S. Physical Therapy reported $214.1M in revenue for Q2 2026, against a consensus estimate of $211.4M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.